In a groundbreaking legal development, Brook Jackson, a whistleblower from within Pfizer, has taken a bold stand against the pharmaceutical giant, accusing the company of engaging in clinical trial fraud to secure (Emergency Use Authorization) EUA for its COVID-19 vaccine. Jackson’s legal team filed a compelling opposition against Pfizer’s request to dismiss the case in a federal court, shedding light on serious allegations of fabrication, falsification, and the deliberate withholding of information.
The Allegations: A Grave Breach of Trust
In the opposition filing, Jackson’s legal team pulls no punches, accusing Pfizer of breaching its contract with the government and undermining the integrity of the clinical trials for its COVID-19 vaccine. The core allegation revolves around Pfizer’s purported fabrication and falsification of reports and results, leading to the EUA being obtained through fraudulent means.
Failure to Deliver on Promises: Ineffectiveness and Hidden Dangers
The crux of Jackson’s claims lies in Pfizer’s failure to deliver a vaccine that meets the promised objectives. Instead of preventing infection, and transmission, and therapeutically treating COVID-19, the whistleblower contends that Pfizer’s vaccine is a dangerous and ineffective drug. Shockingly, the filing alleges a correlation between the Pfizer vaccine and an increase in spike-protein-related diseases, including heart and blood disorders, cancers, autoimmune diseases, neurological diseases, fertility disorders, and even deaths.
Negative Efficacy and Unprecedented Downsides
The opposition filing introduces the term “negative efficacy,” asserting that individuals receiving more doses of the Pfizer vaccine are more likely to contract COVID-19. Furthermore, the legal document highlights staggering downsides associated with Pfizer’s COVID-19 vaccines, indicating a significant increase in adverse health effects since their authorization.
Abandoning Scientific Integrity: A Race for Authorization and Revenue
Jackson contends that Pfizer abandoned scientific principles to secure FDA authorization, enabling the sale of 100 million doses to the United States for a staggering $1.9 billion. The filing alleges that Pfizer engaged in fraudulent practices throughout the design, conduct, analysis, and reporting of its clinical trials, jeopardizing the trust placed in the scientific method and the pursuit of truth.
Detailed Allegations: Unveiling the Clinical Trial Fraud
The opposition filing provides a comprehensive breakdown of the alleged clinical trial fraud, detailing trial designs aimed at concealing negative efficacy, manipulation of inclusion and exclusion determinations, unblinding of subject status, and suppression of available alternatives. Jackson, as a Regional Director at Ventavia Research Group, a key player in Pfizer’s clinical trials, claims to have witnessed these deviations firsthand, presenting them as representative examples of Pfizer’s purported fraud.
Unraveling the Truth Behind Pfizer’s EUA
As the legal battle unfolds, the opposition filing by Brook Jackson offers a compelling narrative of deceit, manipulation, and the betrayal of the public trust in Pfizer’s pursuit of EUA for its COVID-19 vaccine. The gravity of the allegations, if proven true, could have far-reaching implications not only for Pfizer but also for the larger discourse surrounding vaccine safety, efficacy, and the responsibility of pharmaceutical companies to uphold the highest standards of scientific integrity.
